CVS and CIG have been embroiled in an investigation into the spread of the coronavirus.
The investigations, led by the Centers for Disease Control and Prevention (CDC), are investigating the companies’ ability to prevent infections through vaccines and how the vaccine can be tested on patients and not on animals.
CVS has also denied that the tests are flawed, and the company said they would take any action to correct the situation.
The investigation is in its early stages, and CVS is not the only company in the vaccine business that is in the news for its efforts to prevent infection.
The vaccine companies are also involved in other areas of research.
Both are involved in clinical trials, which are used to test new medicines for safety and effectiveness.
For example, the company’s trials of Cervarix, a new vaccine against the coronas pandemic, are being conducted in the US.
The company has also conducted clinical trials of Avastin, a drug that is being tested in the UK, and of ZMapp, a vaccine for HIV that is now in Phase III clinical trials in South Africa.
It is unclear how many other companies are involved with vaccine trials, but according to the FDA, the companies have “committed over $1.2 billion in additional research and development” for the vaccines and related products.
It’s also unclear whether or not these vaccine companies have engaged in any direct or indirect marketing to people.
Both CVS’s chief executive and CIC’s chief medical officer, Dr. Peter Engle, have said that the company is not in the business of marketing.
CIC and CVC have also denied any wrongdoing.
In fact, they have stated that their products are safe, and that there is no evidence to suggest that the vaccines they produce have caused any adverse health effects.
This is despite having been exposed to the same viruses that caused the pandemic.
Both of these companies have had some success in stopping the spread, and in some cases they have been able to prevent more than 10 million people from contracting the coronovirus.
This success has led to a $1 billion investment by the two companies.
CVC has been the most successful vaccine company, spending more than $1 million in funding to help make the vaccines safe.
However, it has also faced criticism for its work.
In addition to the public health efforts, the two vaccine companies also work on other products.
The pharmaceutical giant is the largest producer of vaccines, and it also provides vaccine production services.
In 2018, CVC was the first company to introduce a vaccine to the US market, and also made a deal to buy Pfizer.
The US Department of Justice has launched a criminal investigation into CVC and CVR, and has asked the companies to pay $1,200,000 in restitution.
The two companies have also been under investigation by the FDA.
It was recently reported that the FDA is investigating both companies for failing to provide information on the use of recombinant virus vaccines and for withholding relevant information.
Both companies have said they will not admit to any wrongdoing, and have said it is important to make sure that the vaccine is tested on animals and not humans.
The companies have declined to comment on the investigations, but a statement from the company on the matter said that “we have not and will not provide any further information” about the ongoing investigation.